Fulgent Genetics, Inc. (FLGT) News

Fulgent Genetics, Inc. (FLGT): $21.39

0.25 (+1.18%)

POWR Rating

Component Grades

Momentum

C

Stability

C

Sentiment

Quality

C

Filter FLGT News Items

FLGT News Results

Date Symbol Company Title Start End Change POWR Rating
Loading, please wait...

Latest FLGT News From Around the Web

Below are the latest news stories about FULGENT GENETICS INC that investors may wish to consider to help them evaluate FLGT as an investment opportunity.

The 3 Best Digital Health Stocks for Personalized Medicine

Digital health stocks are becoming increasingly relelvant as more and more people seek greater control over their health.

Alex Sirois on InvestorPlace | November 25, 2023

Fulgent to Participate in the Piper Sandler 35th Annual Healthcare Conference

EL MONTE, Calif., November 14, 2023--Fulgent Genetics, Inc. (NASDAQ: FLGT) ("Fulgent" or the "Company"), a technology-based company with a well-established clinical diagnostic business and a therapeutic development business, today announced that members of its management team are scheduled to participate in the Piper Sandler 35th Annual Healthcare Conference on Tuesday, November 28, 2023.

Yahoo | November 14, 2023

Fulgent Genetics, Inc. (NASDAQ:FLGT) Q3 2023 Earnings Call Transcript

Fulgent Genetics, Inc. (NASDAQ:FLGT) Q3 2023 Earnings Call Transcript November 3, 2023 Operator: Hello, and welcome to the Fulgent Genetics Q3 2023 Earnings Conference Call and Webcast. [Operator Instructions] A question-and-answer session will follow the formal presentation. [Operator Instructions] As a reminder, this conference is being recorded. It’s now my pleasure to turn the call […]

Yahoo | November 5, 2023

Q3 2023 Fulgent Genetics Inc Earnings Call

Q3 2023 Fulgent Genetics Inc Earnings Call

Yahoo | November 4, 2023

Fulgent Shares Data from Two Poster Presentations at SITC 2023 Annual Meeting

EL MONTE, Calif., November 03, 2023--Fulgent Genetics, Inc. (NASDAQ: FLGT) ("Fulgent" or the "Company"), a technology-based company with a well-established clinical diagnostic business and a therapeutic development business, today announced data from two poster presentations being presented tomorrow, November 4, 2023, at the Society for Immunotherapy of Cancer (SITC) 38th Annual Meeting in San Diego, CA.

Yahoo | November 3, 2023

Fulgent Genetics Inc (FLGT) Reports Q3 2023 Financial Results

Core Revenue Grows 17% YoY, Total Revenue Hits $85 Million

Yahoo | November 3, 2023

Fulgent Genetics, Inc. (FLGT) Reports Q3 Loss, Tops Revenue Estimates

Fulgent Genetics, Inc. (FLGT) delivered earnings and revenue surprises of -21.88% and 31.46%, respectively, for the quarter ended September 2023. Do the numbers hold clues to what lies ahead for the stock?

Yahoo | November 3, 2023

Fulgent Reports Third Quarter 2023 Financial Results

EL MONTE, Calif., November 03, 2023--Fulgent Genetics, Inc. (NASDAQ: FLGT) ("Fulgent" or the "Company"), a technology-based company with a well-established clinical diagnostic business and a therapeutic development business, today announced financial results for its third quarter ended September 30, 2023.

Yahoo | November 3, 2023

Fulgent Genetics, Inc. (NASDAQ:FLGT) is definitely on the radar of institutional investors who own 47% of the company

Key Insights Significantly high institutional ownership implies Fulgent Genetics' stock price is sensitive to their...

Yahoo | November 1, 2023

Top 20 Genomics Companies in the World

In this piece, we will take a look at the top 20 genomics companies in the world. If you want to skip our analysis of the genomics industry, then take a look at the Top 5 Genomics Companies in the World. Modern day science has delivered a plethora of advancements that have enabled humans to […]

Yahoo | October 30, 2023


Get Free Updates

Join thousands of investors who get the latest news, insights and top rated picks from StockNews.com!